Gapping down
In reaction to disappointing earnings/guidance: GOGO -9.3%, KWK -5%, MUX -4.3%, ONVO -2.7%, INO -2.5%, AAL -1.2%, EXK -1%, CNVR -0.9%, VET -0.5%
Select metals/mining stocks trading lower: MT -1.8%, HMY -1.8%, GDX -1.4%, AU -1.2%, SLV -0.9%, GOLD -0.9%, CDE -0.8%
Other news: DNDN -61.7% (reaches agreements on terms of financial restructuring), GPRO -5.7% (filed for a $800 mln Class A common stock offering by company and selling stockholders), ALU -4.2% (still checking), NGB -2.6% (weak markets in Greece over night), MRK -2.3% (presents interim data from proof-of-concept study of Merck's investigational Hepatitis C treatment Grazoprevir/Elbasvir in combination with a nucleotide inhibitor), JCP -1% (cautious Barron's report ahead of this week's earnings), PBR -0.6% (may face criminal US investigation for alleged bribery, according to reports, also downgraded to Mkt Perform from Outperform at Cowen)
Analyst comments: EV -2.2% (downgraded to Underweight from Neutral at JP Morgan), WIT -2% (downgraded to Sell at UBS), MYGN -2% (initiated with a Underweight at Morgan Stanley), AEO -1.9% (downgraded to Equal Weight from Overweight at Barclays), ANF -1.4% (downgraded to Neutral from Buy at Janney), VSAT -1% (downgraded to Hold at Needham), GIS -0.7% (downgraded to Sector Perform at RBC Capital Mkts)
In reaction to disappointing earnings/guidance: GOGO -9.3%, KWK -5%, MUX -4.3%, ONVO -2.7%, INO -2.5%, AAL -1.2%, EXK -1%, CNVR -0.9%, VET -0.5%
Select metals/mining stocks trading lower: MT -1.8%, HMY -1.8%, GDX -1.4%, AU -1.2%, SLV -0.9%, GOLD -0.9%, CDE -0.8%
Other news: DNDN -61.7% (reaches agreements on terms of financial restructuring), GPRO -5.7% (filed for a $800 mln Class A common stock offering by company and selling stockholders), ALU -4.2% (still checking), NGB -2.6% (weak markets in Greece over night), MRK -2.3% (presents interim data from proof-of-concept study of Merck's investigational Hepatitis C treatment Grazoprevir/Elbasvir in combination with a nucleotide inhibitor), JCP -1% (cautious Barron's report ahead of this week's earnings), PBR -0.6% (may face criminal US investigation for alleged bribery, according to reports, also downgraded to Mkt Perform from Outperform at Cowen)
Analyst comments: EV -2.2% (downgraded to Underweight from Neutral at JP Morgan), WIT -2% (downgraded to Sell at UBS), MYGN -2% (initiated with a Underweight at Morgan Stanley), AEO -1.9% (downgraded to Equal Weight from Overweight at Barclays), ANF -1.4% (downgraded to Neutral from Buy at Janney), VSAT -1% (downgraded to Hold at Needham), GIS -0.7% (downgraded to Sector Perform at RBC Capital Mkts)